Part II • Skin And Soft Tissue

Chapter 23: Congenital Melanocytic Nevi

Questions: 11
Answered: 0/11
Score: 0%
1 2 3 4 5 6 7 8 9 10 11
Question 1 of 11 GIANT CONGENITAL MELANOCYTIC NEVI (CMN)
When examining a patient with a giant congenital nevocytic nevus, which one of the following features is a consistent finding?
A
A bathing suit distribution
B
Multiple satellite lesions
C
Multiple neurofibromas
D
A verrucous surface texture to the nevus
E
A tan to brown coloration
✓ Correct Answer: D. A verrucous surface texture to the nevus
Clinical Explanation

Giant cell nevi are characterized by a dark, hairy verrucous appearance, and although satellite lesions are commonly seen, they are not a consistent finding.1 Giant cell nevi vary in their anatomic location and accordingly can be found in bathing suit, stocking, or coat sleeve distributions. Sometimes giant cell nevi are associated with neurofibromatosis, but not consistently so. Neurocutaneous manifestations include leptomeningeal extension, meningomyelocele, and spina bifida. Leptomeningeal melanosis is considered to be more likely in the presence of scalp or dorsal spinal cutaneous lesions. Suspicion of these warrants further investigation with magnetic resonance imaging (MRI).

References:
  • 1. Foster RD, Williams ML, Barkovich AJ, Hoffman WY, Mathes SJ, Frieden IJ. Giant congenital melanocytic nevi: the
  • significance of neurocutaneous melanosis in neurologically asymptomatic children. Plast Reconstr Surg 2001;107(4):
  • 933–941
Question 2 of 11 HISTOLOGY OF CONGENITAL AND ACQUIRED NEVI
Which one of the following statements is correct regarding congenital and acquired nevi?
A
Congenital nevi tend to be located more superficially within the dermis compared with acquired nevi.
B
Small, medium, and large congenital nevi each has very different histological features.
C
Congenital nevi differ from acquired nevi in their involvement with skin appendages.
D
Growth of congenital nevi is often disproportionate to overall patient growth.
E
Most types of congenital and acquired nevi generally have extension into muscle and bone.
✓ Correct Answer: C. Congenital nevi differ from acquired nevi in their involvement with skin appendages.
Clinical Explanation

Congenital nevi consist of nevus cells located in the deeper dermis and can invade skin appendages, vessels, and nerves. In contrast, acquired nevi tend to consist of nevus cells that are limited to the papillary and upper reticular dermis and do not involve skin appendages. The histologic appearance of all congenital nevi is largely similar but giant cell nevi differ in that they may have extension into muscle, bone, and dura. After birth, congenital melanocytic nevi (CMN) grow in proportion to the overall increase in body size.1

References:
  • 1. Rhodes AR, Silverman RA, Harrist TJ, Melski JW. A histologic comparison of congenital and acquired nevomelanocytic
  • nevi. Arch Dermatol 1985;121(10):1266–1273
Question 3 of 11 RISK OF MALIGNANT TRANSFORMATION IN CONGENITAL MELANOCYTIC NEVI (CMN)
Which one of the following statements regarding malignant transformation of congenital melanocytic nevi (CMN) is correct?
A
Management with respect to the potential for malignant transformation remains controversial.
B
There is minimal lifetime risk of malignant transformation in smaller CMN.
C
The most common age range for malignant transformation of giant CMN is 10–20 years.
D
Transformation of giant CMN to melanoma occurs in more than a fifth of cases.
E
Malignant transformation carries a better prognosis compared with other melanoma subtypes.
✓ Correct Answer: A. Management with respect to the potential for malignant transformation remains controversial.
Clinical Explanation

The risk of malignant transformation in congenital nevi and their preemptive management is a controversial topic on which there are many opinions. This is because many factors remain uncertain, such as the true lifetime risk of malignant change for any given lesion, and the impact of prophylactic excision in reducing development of subsequent cutaneous or noncutaneous malignancy. The lifetime risk of malignant change is probably 1–2% for small congenital nevi. The risk in medium congenital melanocytic nevi (CMN) is uncertain, and neither small- nor medium-sized CMN are likely to change before puberty. In contrast, giant CMN have a 5–10% risk of malignant transformation, and half of these will occur between the ages of 3 and 5 years. The size and site of a giant CMN as well as the number of satellite lesions appear to impact the risk of malignant transformation. Trunk lesions have a higher risk of malignant transformation as do those greater than 20 cm in diameter. When malignant transformation occurs in giant nevi, the prognosis is poor.1,2 If a diagnosis of melanoma is found following removal of a CMN, screening should be undertaken for NRSA and BRAF mutations.3

References:
  • 1. Krengel S, Marghoob AA. Current management approaches for congenital melanocytic nevi. Dermatol Clin
  • 2012;30(3):377–387
  • 2. Marghoob AA, Borrego JP, Halpern AC. Congenital melanocytic nevi: treatment modalities and management options.
  • Semin Cutan Med Surg 2007;26(4):231–240
  • 3. Kinsler VA, O’Hare P, Bulstrode N, et al. Melanoma in congenital melanocytic naevi. Br J Dermatol 2017;176(5):1131–1143
Question 4 of 11 MANAGEMENT OF GIANT CONGENITAL MELANOCYTIC NEVI (CMN)
Which one of the following is probably the most important indication to treat a giant congenital melanocytic nevi (CMN)?
A
Cosmetic appearance
B
Parental request
C
Psychological effects
D
Risk of malignant change
E
Site and size of lesion
✓ Correct Answer: D. Risk of malignant change
Clinical Explanation

(CMN)? All of the options are reasonable reasons for surgical removal of a congenital nevus. However, the most important reason for treatment is the potential risk of malignant change. Cosmesis will often be very important to parents and patients. It is particularly important to patients as they begin to develop social awareness. The presence of large congenital melanocytic nevi (CMN) can lead to both social and behavioral consequences. The site, size, and location of the lesion and availability of tissue for reconstruction play a significant role in decision-making, especially if this makes the lesion difficult to monitor accurately. Both scarring from surgery and the original nevus can carry significant potential psychological effects, so this must be discussed in depth prior to embarking on any treatment plan.1,2

References:
  • 1. Price HN. Congenital melanocytic nevi: update in genetics and management. Curr Opin Pediatr 2016;28(4):476–482
  • 2. Marghoob AA. Congenital melanocytic nevi. Evaluation and management. Dermatol Clin 2002;20(4):607–616, viii
Question 5 of 11 MANAGEMENT OF CONGENITAL MELANOCYTIC NEVI (CMN)
When planning management of congenital melanocytic nevi (CMN) which one of the following statements is correct?
A
Nongiant cell congenital nevi should be assessed three times per year.
B
Early excision is not warranted in lesions just because they are difficult to monitor.
C
Any atypical congenital nevi should be excised regardless of size.
D
Reconstruction of giant CMN will require tissue expansion to achieve primary closure.
E
Laser or curettage are recommended for smaller lesions and have low recurrence rates.
✓ Correct Answer: C. Any atypical congenital nevi should be excised regardless of size.
Clinical Explanation

5. When planning management of congenital melanocytic nevi (CMN), which one of the following statements is correct? Early excision of small and medium congenital nevi is warranted if they are difficult to monitor (e.g., on the back or scalp) or if they have atypical features such as color variegation, abnormal borders, or growth. Nongiant nevi can be observed on an annual basis (not every 4 months) unless suspicious, in which case a diagnostic biopsy is performed instead. Giant congenital melanocytic nevi (CMN) should be excised completely as soon as possible after appropriate imaging. Reconstruction often requires a combination of tissue expansion, grafts, and flaps but is dependent on size and anatomic location. For example, giant CMN representing 1% total body surface area (TBSA) located on the trunk may be closed directly without expansion techniques. Laser and curettage are not recommended for managing CMN as they are associated with high recurrence rates.1,2

References:
  • 1. Price HN. Congenital melanocytic nevi: update in genetics and management. Curr Opin Pediatr 2016;28(4):476–482
  • 2. Marghoob AA. Congenital melanocytic nevi. Evaluation and management. Dermatol Clin 2002;20(4):607–616, viii
Question 6 of 11 DIAGNOSIS OF PIGMENTED SKIN LESIONS
A baby is found to have a 3-cm-diameter, steel-blue macule in the lumbosacral region soon after birth. Which one of the following is the most likely diagnosis?
A
Mongolian spot
B
Blue nevus
C
Spitz nevus
D
Café au lait spot
E
Halo nevus
✓ Correct Answer: A. Mongolian spot
Clinical Explanation

Mongolian spots are more common in races with darkly pigmented skin and can vary from a couple of centimeters to 20 cm. They are present at birth and usually disappear during childhood. In contrast, blue nevi usually appear in late adolescence and are small (less than 1 cm). They are typically blue or black and can be located on the hands, feet, head, or neck. A Spitz nevus is a red or pigmented dome-shaped papule that usually appears at birth and is commonly found on the head or neck. Excision is normally recommended. Café au lait spots are well-circumscribed, homogeneous, macular, coffee-colored lesions often seen with neurofibromatosis. A halo nevus has a white halo around the nevus due to a lymphocytic reaction and most commonly is found on the back during puberty.1–3

References:
  • 1. Zhong CS, Huang JT, Nambudiri VE. Revisiting the history of the “Mongolian spot”: the background and implications of
  • a medical term used today. Pediatr Dermatol 2019;36(5):755–757
  • 2. Marghoob AA. Congenital melanocytic nevi. Evaluation and management. Dermatol Clin 2002;20(4):607–616, viii
  • 3. Kaushik A, Natsis N, Gordon SC, Seiverling EV. A practical review of dermoscopy for pediatric dermatology part I: Me-
  • lanocytic growths. Pediatr Dermatol 2020;37(5):789–797
Question 7 of 11 CLINICAL PRESENTATION OF PIGMENTED SKIN LESIONS
A baby girl presents with a yellowish waxy plaque on the scalp. She is otherwise fit and well. What is the most likely diagnosis?
A
Dysplastic nevus
B
Sebaceous nevus
C
Nevus spilus
D
Epidermal nevus
E
Basal cell carcinoma
✓ Correct Answer: B. Sebaceous nevus
Clinical Explanation

A sebaceous nevus is a solitary yellowish waxy congenital plaque usually found on the scalp. Alternatively, they can be located on the face, neck, or forehead. They consist of overgrown epidermis with hair follicles and sebaceous glands and are classified as a type of benign hair follicle tumor. However, they do also have a risk of malignant transformation to basal cell carcinoma (BCC) (10 or 15%) later in life and for this reason they are often treated surgically. Dysplastic (atypical) nevi often occur during or after puberty and are slightly odd-looking nevi with irregular edges, altered pigmentation, and are usually larger than 6 mm in diameter. They are often referred to as “changing moles” in order to exclude melanoma and are generally treated surgically with complete excision. Dysplastic nevi can be mild, moderate, or severely dysplastic according to their histologic appearance. Many centers will treat severely dysplastic nevi the same as in situ melanoma, i.e., with 5-mm wide excision. Nevus spilus (speckled lentiginous nevi) are tan colored macules that measure 1–4 cm in diameter and have speckling with dark brown papules or macules 1–6 mm in diameter. They usually present before age 2 as acquired lesions but may be congenital in some cases. They do not usually require intervention but may be removed surgically or treated with laser therapy. Epidermal nevi are skin lesions involving overgrowth of the epidermis. They include linear nevi which occur on the trunk and limbs, first appearing at birth or shortly after. They comprise of tan or brown colored warty macules or papules, without plaques or hair. Again surgery or laser treatment is often performed for these lesions. Basal cell carcinomas are slow-growing, nonmelanoma skin cancers seen in older age groups. They almost never metastasize and have an association with sebaceous nevi as described above. Their management may be surgical, topical, or with radiotherapy depending on their subtype.1–4

References:
  • 1. Jiao L, Han X, Xu J, Sun J, Ma L. Four pediatric cases of secondary neoplasms arising in nevus sebaceous. Dermatol Ther
  • (Heidelb) 2020;33(6):e13762
  • 2. Constant E, Davis DG. The premalignant nature of the sebaceous nevus of Jadassohn. Plast Reconstr Surg 1972;50(3):2
  • 57–259
  • 3. Mehregan AH, Pinkus H. Life history of organoid nevi. Special reference to nevus sebaceus of Jadassohn. Arch Dermatol
  • 1965;91:574–588
  • 4. Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceus: a study of 596 cases. J Am Acad Dermatol 2000;
  • 42(2 Pt 1):263–268
Question 8 of 11 CONGENITAL MELANOCYTIC NEVI (CMN)
What is the key difference between a tardive congenital nevus and a congenital nevus?
A
The timing of first presentation
B
The rate of growth
C
The histological appearance
D
The surgical management
E
The color and texture
✓ Correct Answer: A. The timing of first presentation
Clinical Explanation

Melanocytic nevi occurring in infancy or during the first 2 years of life are classified as tardive congenital melanocytic nevi (CMN) or congenital nevus-like nevi (CNLN). They are clinically and histologically indistinguishable from CMN. Therefore, the two subtypes are treated in the same manner with regular observation or surgical excision. The rate of growth itself is not different; it is purely that presentation is later.1,2

References:
  • 1. Schaffer JV. Update on melanocytic nevi in children. Clin Dermatol 2015;33(3):368–386
  • 2. Moustafa D, Blundell AR, Hawryluk EB. Congenital melanocytic nevi. Curr Opin Pediatr 2020;32(4):491–497
Question 9 of 11 NEUROCUTANEOUS MELANOSIS
When seeing an infant with a diagnosis of neurocutaneous melanosis, which one of the following would be most expected?
A
Muscle weakness
B
Headache and photophobia
C
Microtia
D
More than five congenital nevi
E
Limb anomalies
✓ Correct Answer: B. Headache and photophobia
Clinical Explanation

expected? Melanocytic proliferation within the brain parenchyma or leptomeninges (the combined pia and arachnoid mater) is described as neuromelanosis. When seen in combination with congenital melanocytic nevi (CMN) this is called neurocutaneous melanosis and raised intracranial pressure can be a problem for such patients. Symptoms of this include headache, photophobia, lethargy, and recurrent vomiting. Ultimately this condition can result in seizures, developmental delay, cranial nerve palsies, sensorimotor deficits, and bladder and bowel dysfunction. Where there is central nervous system (CNS) involvement, patients are usually symptomatic by 2 years of age. Investigation with magnetic resonance imaging (MRI) is warranted in the first 4 months of life. Unfortunately, there is little treatment that can be offered other than managing intracranial pressure issues. In general, where neurologic symptoms are present, prognosis is very poor. The other options listed are not specifically related to this condition.1–3

References:
  • 1. Lee JH, Jackson AB, Ren Y, Rao KI. Neurocutaneous melanosis: a rare manifestation of congenital melanocytic nevus.
  • BMJ Case Rep 2019;12(8):e227621
  • 2. Alikhan A, Ibrahimi OA, Eisen DB. Congenital melanocytic nevi: where are we now? Part I. Clinical presentation,
  • epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis. J Am Acad Dermatol
  • 2012;67(4):495.e1–495.e17, quiz 512–514
  • 3. Fledderus AC, Franke CJJ, Eggen CAM, et al. Outcomes and measurement instruments used in congenital melanocytic
  • naevi research: a systematic review. J Plast Reconstr Aesthet Surg 2020;73(4):703–715
Question 10 of 11 CLINICAL PRESENTATION OF PIGMENTED SKIN LESIONS
An Asian newborn baby has a right-sided, blue-brown periocular macule of 2 cm diameter. What is the most likely diagnosis?
A
Nevus of Ito
B
Nevus of Ota
C
Spitz nevus
D
Tardive congenital nevus
E
Mongolian spot
✓ Correct Answer: B. Nevus of Ota
Clinical Explanation

The nevus of Ota has an onset at birth or within the first year of life and during puberty. It is especially common in Asians and blacks. It appears as a blue-brown unilateral periocular macule varying in size from a few centimeters to one which affects half of the face and follows the trigeminal nerve distribution. The nevus of Ito usually appears at birth and is typically seen in Asians and blacks. It appears as a large blue- brown lesion on the posterior shoulder innervated by the supraclavicular and lateral cutaneous brachial nerves. Spitz nevi are red or pigmented, smooth, dome-shaped papules with telangiectasia measuring about 8 mm in diameter. They usually appear at birth and are also called juvenile melanoma. They are best managed with surgical excision for both diagnostic and therapeutic purposes. Tardive congenital nevi are congenital nevi that develop within the first 2 years after birth. They are managed the same as other congenital nevi with either monitoring or removal as they carry a small risk of malignant transformation. A Mongolian spot is a steel-blue macula present at birth or during first few weeks of life located in the lumbosacral area. Size of these lesions ranges from a few centimeters to 20 cm or more. They are more common in darkly pigmented skin and usually disappear in early childhood.1–4

References:
  • 1. Tse JY, Walls BE, Pomerantz H, et al. Melanoma arising in a nevus of Ito: novel genetic mutations and a review of the
  • literature on cutaneous malignant transformation of dermal melanocytosis. J Cutan Pathol 2016;43(1):57–63
  • 2. Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendations for the categorization of cutaneous
  • features of congenital melanocytic nevi. J Am Acad Dermatol 2013;68(3):441–451
  • 3. Price HN. Congenital melanocytic nevi: update in genetics and management. Curr Opin Pediatr 2016;28(4):476–482
  • 4. Marghoob AA. Congenital melanocytic nevi. Evaluation and management. Dermatol Clin 2002;20(4):607–616, viii
Question 11 of 11 CLINICAL PRESENTATION OF PIGMENTED SKIN LESIONS
An adolescent male is seen in clinic with a 10-cm-diameter, tan-colored, hairy lesion on the right shoulder. It has been present for 6 months. What is the most likely diagnosis?
A
Becker’s nevus
B
Café au lait spot
C
Halo nevus
D
Dysplastic nevus
E
Spitz nevus
✓ Correct Answer: A. Becker’s nevus
Clinical Explanation

A Becker’s nevus (pigmented hairy epidermal nevus) is a late-onset birthmark which is first observed in adolescence as a tan to brown hairy lesion most commonly affecting one’s shoulder. The hairs and pigmentation are often treated with laser therapy. Café au lait spots may be present at birth, but usually develop in childhood. They are well-circumscribed, oval macular lesions that have a homogenous milky coffee color. They are often associated with neurofibromatosis. Halo nevi are small, brown-colored nevi with a surrounding white halo. The white halo represents a lymphocytic reaction and such lesions are most commonly found on upper backs of teenagers. Dysplastic nevi most often develop after adolescence and appear as an irregular, brown-colored skin lesion with areas of different pigmentation, and are most commonly found on the trunk. They are usually larger than 6 mm and should be treated with surgical excision. Spitz nevi are red or pigmented, smooth, dome-shaped papules with telangiectasia measuring about 8 mm in diameter. They usually appear at birth and are also called juvenile melanoma. They are best managed with surgical excision for both diagnostic and therapeutic purposes.1–4

References:
  • 1. Becker SW. Concurrent melanosis and hypertrichosis in distribution of nevus unius lateris. Arch Derm Syphilol 1949;
  • 60(2):155–160
  • 2. Patel P, Malik K, Khachemoune A. Sebaceus and Becker’s nevus: overview of their presentation, pathogenesis, associa-
  • tions, and treatment. Am J Clin Dermatol 2015;16(3):197–204
  • 3. Patrizi A, Medri M, Raone B, Bianchi F, Aprile S, Neri I. Clinical characteristics of Becker’s nevus in children: report of
  • 118 cases from Italy. Pediatr Dermatol 2012;29(5):571–574
  • 4. Danarti R, König A, Salhi A, Bittar M, Happle R. Becker’s nevus syndrome revisited. J Am Acad Dermatol 2004;51(6): 965–969
  • PART III
  • Head and Neck

🎉 Chapter Completed!

Proceed to Next Chapter → Back to All Chapters